Your browser doesn't support javascript.
loading
Evaluation of Mesenchymal Stem Cell Therapy for Sepsis: A Randomized Controlled Porcine Study.
Horak, Jan; Nalos, Lukas; Martinkova, Vendula; Tegl, Vaclav; Vistejnova, Lucie; Kuncova, Jitka; Kohoutova, Michaela; Jarkovska, Dagmar; Dolejsova, Martina; Benes, Jan; Stengl, Milan; Matejovic, Martin.
Afiliación
  • Horak J; First Medical Department, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
  • Nalos L; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czechia.
  • Martinkova V; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czechia.
  • Tegl V; Department of Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
  • Vistejnova L; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czechia.
  • Kuncova J; Third Department of Surgery, University Hospital Motol and First Medical School, Charles University, Prague, Czechia.
  • Kohoutova M; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czechia.
  • Jarkovska D; Department of Anesthesia and Intensive Care Medicine, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
  • Dolejsova M; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czechia.
  • Benes J; Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
  • Stengl M; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czechia.
  • Matejovic M; Department of Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
Front Immunol ; 11: 126, 2020.
Article en En | MEDLINE | ID: mdl-32117276
Background: Treatment with mesenchymal stem cells (MSCs) has elicited considerable interest as an adjunctive therapy in sepsis. However, the encouraging effects of experiments with MSC in rodents have not been adequately studied in large-animal models with better relevance to human sepsis. Objectives: Here, we aimed to assess safety and efficacy of bone marrow-derived MSCs in a clinically relevant porcine model of progressive peritonitis-induced sepsis. Methods: Thirty-two anesthetized, mechanically ventilated, and instrumented pigs were randomly assigned into four groups (n = 8 per group): (1) sham-operated group (CONTROL); (2) sham-operated group treated with MSCs (MSC-CONTROL); (3) sepsis group with standard supportive care (SEPSIS); and (4) sepsis group treated with MSCs (MSC-SEPSIS). Peritoneal sepsis was induced by inoculating cultivated autologous feces. MSCs (1 × 106/kg) were administered intravenously at 6 h after sepsis induction. Results: Before, 12, 18, and 24 h after the induction of peritonitis, we measured systemic, regional, and microvascular hemodynamics, multiple-organ functions, mitochondrial energy metabolism, systemic immune-inflammatory response, and oxidative stress. Administration of MSCs in the MSC-CONTROL group did not elicit any measurable acute effects. Treatment of septic animals with MSCs failed to mitigate sepsis-induced hemodynamic alterations or the gradual rise in Sepsis-related organ failure assessment scores. MSCs did not confer any protection against sepsis-mediated cellular myocardial depression and mitochondrial dysfunction. MSCs also failed to modulate the deregulated immune-inflammatory response. Conclusion: Intravenous administration of bone marrow-derived MSCs to healthy animals was well-tolerated. However, in this large-animal, clinically relevant peritonitis-induced sepsis model, MSCs were not capable of reversing any of the sepsis-induced disturbances in multiple biological, organ, and cellular systems.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sepsis / Trasplante de Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sepsis / Trasplante de Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article Pais de publicación: Suiza